Overview

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite

Status:
Withdrawn
Trial end date:
2020-08-15
Target enrollment:
Participant gender:
Summary
This multicenter, randomized, double-blind, placebo-controlled clinical trial will evaluate the efficacy and safety of intravenous Sodium Nitrite Injection for treatment of patients infected with COVID-19 who develop lung injury and require mechanical ventilation.
Phase:
Phase 2
Details
Lead Sponsor:
Hope Pharmaceuticals